RS53999B1 - Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor - Google Patents

Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor

Info

Publication number
RS53999B1
RS53999B1 RS20150319A RSP20150319A RS53999B1 RS 53999 B1 RS53999 B1 RS 53999B1 RS 20150319 A RS20150319 A RS 20150319A RS P20150319 A RSP20150319 A RS P20150319A RS 53999 B1 RS53999 B1 RS 53999B1
Authority
RS
Serbia
Prior art keywords
letters
thickness
front panel
sides
numbers
Prior art date
Application number
RS20150319A
Other languages
English (en)
Serbian (sr)
Inventor
Sreenivasa Reddy Mundla
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of RS53999B1 publication Critical patent/RS53999B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RS20150319A 2005-07-22 2006-06-29 Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor RS53999B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70164105P 2005-07-22 2005-07-22
PCT/US2006/025377 WO2007018818A1 (en) 2005-07-22 2006-06-29 A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor

Publications (1)

Publication Number Publication Date
RS53999B1 true RS53999B1 (sr) 2015-10-30

Family

ID=37450942

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20150319A RS53999B1 (sr) 2005-07-22 2006-06-29 Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor

Country Status (16)

Country Link
US (1) US7872020B2 (enExample)
EP (1) EP1910370B1 (enExample)
JP (1) JP5242391B2 (enExample)
BR (1) BRPI0613639A2 (enExample)
CA (1) CA2616196C (enExample)
DK (1) DK1910370T3 (enExample)
ES (1) ES2542425T3 (enExample)
HR (1) HRP20150474T1 (enExample)
HU (1) HUE025209T2 (enExample)
IL (1) IL188181A (enExample)
MX (1) MX2008001020A (enExample)
PL (1) PL1910370T3 (enExample)
PT (1) PT1910370E (enExample)
RS (1) RS53999B1 (enExample)
SI (1) SI1910370T1 (enExample)
WO (1) WO2007018818A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR081810A1 (es) 2010-04-07 2012-10-24 Bayer Cropscience Ag Piridinilpirazoles biciclicos
AU2012281281B2 (en) * 2011-07-13 2017-06-01 Tiumbio Co., Ltd 2-pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors
EP2917365B1 (en) 2012-11-12 2020-03-11 Institució Catalana de Recerca i Estudis Avançats Methods and kits for the prognosis of colorectal cancer
BR112015023261A2 (pt) 2013-03-14 2017-07-18 Massachusetts Inst Technology composições e métodos para expansão e cultura de células-tronco epiteliais
JP6773645B2 (ja) 2014-09-03 2020-10-21 ザ ブリガム アンド ウィミンズ ホスピタル,インコーポレイテッド 聴覚障害の治療のための内耳毛細胞を生成するための組成物、システムおよび方法
HK1247861A1 (zh) 2015-01-30 2018-10-05 President And Fellows Of Harvard College 用於癌症治疗的肿瘤周围和肿瘤内部材料
US10822337B2 (en) 2015-04-01 2020-11-03 Rigel Pharmaceuticals, Inc. TGF-β inhibitorC
EP3313420B1 (en) 2015-06-25 2024-03-13 The Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
KR102738306B1 (ko) 2015-12-15 2024-12-03 브리스톨-마이어스 스큅 컴퍼니 Cxcr4 수용체 길항제
WO2017120543A1 (en) 2016-01-08 2017-07-13 Massachusetts Institute Of Technology Production of differentiated enteroendocrine cells and insulin producing cells
US10201540B2 (en) 2016-03-02 2019-02-12 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I
US11260130B2 (en) 2016-03-02 2022-03-01 Frequency Therapeutics, Inc. Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV
US10213511B2 (en) 2016-03-02 2019-02-26 Frequency Therapeutics, Inc. Thermoreversible compositions for administration of therapeutic agents
AU2017235461B2 (en) 2016-03-15 2023-02-23 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion
CN109548403A (zh) 2016-07-07 2019-03-29 苏州科睿思制药有限公司 Galunisertib的晶型及其制备方法和用途
WO2018068759A1 (zh) 2016-10-14 2018-04-19 江苏恒瑞医药股份有限公司 五元杂芳环并桥环类衍生物、其制备方法及其在医药上的应用
AU2017386417B2 (en) 2016-12-30 2022-07-14 Frequency Therapeutics, Inc. 1H-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells
US11111248B2 (en) 2017-03-17 2021-09-07 Hangzhou Solipharma Co., Ltd. Crystal form of 2-(6-methyl-pyridin-2-yl)-3-yl-[6-amido-quinolin-4-yl]-5,6-dihydro-4H-pyrrolo[1,2-B]pyrazole, preparation method therefor and pharmaceutical composition thereof
US10995083B2 (en) 2017-03-21 2021-05-04 Hangzhou Solipharma Co., Ltd. Cocrystal of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4H-pyrrole[1,2-b]pyrazole, preparation method therefor, and pharmaceutical composition
WO2019042383A1 (zh) * 2017-08-31 2019-03-07 苏州科睿思制药有限公司 Galunisertib的晶型及其制备方法和用途
WO2019105082A1 (zh) * 2017-11-30 2019-06-06 苏州科睿思制药有限公司 Galunisertib的晶型及其制备方法和用途
WO2019137027A1 (zh) * 2018-01-12 2019-07-18 苏州科睿思制药有限公司 Galunisertib的晶型及其制备方法和用途
AU2019240065A1 (en) 2018-03-20 2020-09-24 Icahn School Of Medicine At Mount Sinai Kinase inhibitor compounds and compositions and methods of use
US20210254006A1 (en) 2018-06-06 2021-08-19 Ideaya Biosciences, Inc. Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using lactam compounds
US11617745B2 (en) 2018-08-17 2023-04-04 Frequency Therapeutics, Inc. Compositions and methods for generating hair cells by downregulating FOXO
JP2021533788A (ja) 2018-08-17 2021-12-09 フリークエンシー セラピューティクス インコーポレイテッド Jag−1を上方制御することにより有毛細胞を生成するための組成物及び方法
EP3906233B1 (en) 2018-12-31 2024-01-31 Icahn School of Medicine at Mount Sinai Kinase inhibitor compounds and compositions and methods of use
CN115282280A (zh) * 2022-08-12 2022-11-04 中国科学技术大学 TGF-β1信号抑制剂的新用途
AU2024265078A1 (en) 2023-05-04 2025-12-11 Revolution Medicines, Inc. Combination therapy for a ras related disease or disorder
GB202309553D0 (en) 2023-06-24 2023-08-09 Ucl Business Ltd Compostions and uses thereof
US20250049810A1 (en) 2023-08-07 2025-02-13 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder
WO2025080946A2 (en) 2023-10-12 2025-04-17 Revolution Medicines, Inc. Ras inhibitors
WO2025171296A1 (en) 2024-02-09 2025-08-14 Revolution Medicines, Inc. Ras inhibitors
WO2025240847A1 (en) 2024-05-17 2025-11-20 Revolution Medicines, Inc. Ras inhibitors
WO2025255438A1 (en) 2024-06-07 2025-12-11 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287857B6 (sk) 2001-05-24 2012-01-04 Eli Lilly And Company Novel pyrrole derivatives as pharmaceutical agents
WO2004048383A1 (en) * 2002-11-21 2004-06-10 Eli Lilly And Company Mixed lineage kinase modulators
UA80571C2 (en) * 2002-11-22 2007-10-10 Lilly Co Eli Quinolinyl-pyrrolopyrazoles

Also Published As

Publication number Publication date
HRP20150474T1 (xx) 2015-06-05
CA2616196C (en) 2012-08-21
JP2009502780A (ja) 2009-01-29
IL188181A0 (en) 2008-03-20
IL188181A (en) 2014-05-28
CA2616196A1 (en) 2007-02-15
JP5242391B2 (ja) 2013-07-24
US20100120854A1 (en) 2010-05-13
US7872020B2 (en) 2011-01-18
MX2008001020A (es) 2008-03-25
PL1910370T3 (pl) 2015-09-30
SI1910370T1 (sl) 2015-06-30
BRPI0613639A2 (pt) 2012-02-22
HUE025209T2 (en) 2016-03-29
WO2007018818A1 (en) 2007-02-15
DK1910370T3 (en) 2015-06-08
EP1910370B1 (en) 2015-04-22
ES2542425T3 (es) 2015-08-05
PT1910370E (pt) 2015-06-30
EP1910370A1 (en) 2008-04-16

Similar Documents

Publication Publication Date Title
RS53999B1 (sr) Piridin hinolin supstituisani pirolo [1,2-b] pirazol monohidrat kao tgf-beta inhibitor
US5760367A (en) Apparatus and method of engraving indicia on gemstones, and gemstones, produced thereby
US5536558A (en) Illuminated display using ambient natrual or artificial light
CN105814623B (zh) 表面上的发光图案
CN102275448B (zh) 高精细透光图案塑料面板的制作方法
US5419940A (en) Colorized acrylic award assembly and method of making
US5753887A (en) Apparatus for laser engraving indicia on gemstones
Dumont et al. Laser writing of 2D data matrices in glass
Ding et al. Single-Step femtosecond laser structuring of multifunctional colorful metal surface and its origin
WO1992022226A1 (en) Simulated objects
CN203730486U (zh) 一种双面胶定位粘贴工装
GB2445129A (en) Screen printing apparatus and screen printing method
ATE154199T1 (de) Verfahren zum anbringen von gravuren auf eine oberfläche eines eiskörpers, insbesondere eines solchen aus klareis,
CA2161955A1 (en) Rapid color shading process
CN204936375U (zh) 一种贵金属磨砂镜面仿印薄片
MX2014011914A (es) Herramientas para elaborar articulos retrorreflectivos.
KR101814184B1 (ko) 메모리 캔들 홀더
YU49429B (sh) Postupak za izradu informacione ploče sa natpisom radnje ili firme koji treba da simulira trodimenzionalnost slova, brojeva i drugih znakova
CN1144766C (zh) 紫外线激发下再现三维彩色发光图案的制备方法
CN214775131U (zh) 一种树脂光栅板
CN117577710B (zh) 一种增加彩色前板与光伏组件牢度的制作方法
CN206177850U (zh) 光学滤光片水检台
JP7133695B1 (ja) 装飾体、装飾体製造装置及び装飾体製造方法
WO2009016750A1 (ja) 服飾用物品、および服飾用物品の表示部の製造方法
CN209674620U (zh) 广告平面设计的教学辅助装置